Clinical application of nasal nitric oxide measurement in pediatric airway diseases

Pediatric Pulmonology

Volumn 50, Issue 1, 2015, Pages 85-99

  Manna, Angelo ^a   Montella, Silvia ^a   Maniscalco, Mauro ^b   Maglione, Marco ^a   Santamaria, Francesca ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Hospital S Maria Della Pieta   (Italy)

Author keywords

Allergic rhinitis; Allergy; Children; Cystic fibrosis; Cystic fibrosis (CF); Nasal nitric oxide; Nitric oxide (NO); Primary ciliary dyskinesia

Indexed keywords

NITRIC OXIDE; BIOLOGICAL MARKER;

ADENOID HYPERTROPHY; ALLERGIC RHINITIS; CILIARY DYSKINESIA; CYSTIC FIBROSIS; MEASUREMENT; NOSE; NOSE POLYP; PEDIATRICS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RHINOSINUSITIS; CHILD; EXHALATION; HUMAN; METABOLISM; RESPIRATORY TRACT DISEASES;

BIOMARKERS; CHILD; EXHALATION; HUMANS; NITRIC OXIDE; NOSE; RESPIRATORY TRACT DISEASES;

EID: 84964693219     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23094     Document Type: Review

References (121)

1. Lefevere L, Willems T, Lindberg S, Jorissen M. Nasal nitric oxide. Acta Otorhinolaryngol Belg 2000;54:271-280.
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
3. Maniscalco M, Sofia M, Pelaia G. Nitric oxide in upper airways inflammatory diseases. Inflamm Res 2007;56:58-69.
4. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C, Paolocci N, Ambs S, et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 2008;45:18-31.
5. Wink DA, Hines HB, Cheng RY, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol 2011; 89:873-891.
6. Pifferi M, Bush A, Maggi F, Michelucci A, Ricci V, Conidi ME, Cangiotti AM, Bodini A, Simi P, Macchia P, et al. Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia. Eur Respir J 2011;37:572-577.
7. Chang CC, Lien SH, Liu TY, Hua YM, Lee CM, Yuh YS. Nasal nitric oxide in infants before and after extubation. Pediatr Pulmonol 2008;43:1072-1077.
8. Lundberg JO, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J, Anggåard A, Hökfelt T, Lundberg JM, Alving K. High nitric oxide production in human paranasal sinuses. Nat Med 1995;1: 370-373.
9. Maniscalco M, Sofia M, Weitzberg E, De Laurentiis G, Stanziola A, Rossillo V, Lundberg JO. Humming-induced release of nasal nitric oxide for assessment of sinus obstruction in allergic rhinitis: pilot study. Eur J Clin Invest 2004;34:555-560.
10. Ratjen F, Kavuk I, Gärtig S, Wiesemann HG, Grasemann H. Airway nitric oxide in infants with acute wheezy bronchitis. Pediatr Allergy Immunol 2000;11:230-235.
11. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR. American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-615.
12. Piacentini GL, Cattazzo E, Tezza G, Peroni DG. Exhaled nitric oxide in pediatrics: what is new for practice purposes and clinical research in children? J Breath Res 2012;6:027103.
13. Munakata M. Exhaled nitric oxide (FeNO) as a non-invasive marker of airway inflammation. Allergol Int 2012;61:365-372.
14. Manna A, Caffarelli C, Varini M, Povesi Dascola C, Montella S, Maglione M, Sperlì F, Santamaria F. Clinical application of exhaled nitric oxide measurement in pediatric lung diseases. Ital J Pediatr 2012;38:74-84.
15. Maniscalco M, Pelaia G, Sofia M. Exhaled nasal nitric oxide during humming: potential clinical tool in sinonasal disease? Biomark Med 2013;7:261-266.
16. Columbo M, Wong B, Panettieri RA Jr, Rohr AS. Asthma in the elderly: the role of exhaled nitric oxide measurements. Respir Med 2013;107:785-787.
17. Mahr TA, Malka J, Spahn JD. Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice. Allergy Asthma Proc 2013;34:210-219.
18. Hsu JY, Huang WC, Huang PL, Cheng YW, Chou MC. Usefulness of offline fractional exhaled nitric oxide measurements in the elderly asthmatic patients. Allergy Asthma Proc 2013;34:434-438.
19. Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, Baktai G, Bartoloni L, Eber E, Escribano A, Haarman E, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J 2009; 34:1264-1276.
20. Strippoli MP, Frischer T, Barbato A, Snijders D, Maurer E, Lucas JS, Eber E, Karadag B, Pohunek P, Zivkovic Z, et al. ERS Task Force on Primary Ciliary Dyskinesia in Children. Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J 2012;39:1482-1491.
21. Balfour-Lynn IM, Laverty A, Dinwiddie R. Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child 1996;75: 319-322.
22. Lundberg JO, Nordvall SL, Weitzberg E, Kollberg H, Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child 1996;75:323-326.
23. Dötsch J, Demirakça S, Terbrack HG, Hüls G, Rascher W, Kühl PG. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 1996;9:2537-2540.
24. Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol 1997;117:113-117.
25. Baraldi E, Azzolin NM, Biban P, Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am J Respir Crit Care Med 1997;155:1680-1683.
26. Baraldi E, Azzolin NM, Carra S, Dario C, Marchesini L, Zacchello F. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study. Respir Med 1998;92:558-561.
27. Baraldi E, Azzolin NM, Cracco A, Zacchello F. Reference values of exhaled nitric oxide for healthy children 6-15 years old. Pediatr Pulmonol 1999;27:54-58.
28. Grasemann H, Gärtig SS, Wiesemann HG, Teschler H, Konietzko N, Ratjen F. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur Respir J 1999;13:114-118.
29. Henriksen AH, Sue-Chu M, Holmen TL, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyper-responsiveness. Eur Respir J 1999;13:301-306.
30. Karadag B, James AJ, Gültekin E, Wilson NM, Bush A. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur Respir J 1999;13:1402-1405.
31. Qian W, Djupesland PG, Chatkin JM, McClean P, Furlott H, Chapnik JS, Zamel N, Haight JS. Aspiration flow optimized for nasal nitric oxide measurement. Rhinology 1999;37:61-65.
32. Daya H, Qian W, McClean P, Haight J, Zamel N, Papsin BC, Forte V. Nasal nitric oxide in children: a novel measurement technique and normal values. Laryngoscope 2002;112:1831-1835.
33. Williams O, Rafferty GF, Hannam S, Milner AD, Greenough A. Nasal and lower airway levels of nitric oxide in prematurely born infants. Early Hum Dev 2003;72:67-73.
34. Csoma Z, Bush A, Wilson NM, Donnelly L, Balint B, Barnes PJ, Kharitonov SA. Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia. Chest 2003;124:633-638.
35. Corbelli R, Bringolf-Isler B, Amacher A, Sasse B, Spycher M, Hammer J. Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia. Chest 2004;126:1054-1059.
36. Edwards EA, Douglas C, Broome S, Kolbe J, Jensen CG, Dewar A, Bush A, Byrnes CA. Nitric oxide levels and ciliary beat frequency in indigenous New Zealand children. Pediatr Pulmonol 2005;39:238-246.
37. American Thoracic Society and European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-930.
38. Struben VM, Wieringa MH, Mantingh CJ, Bommelje C, Don M, Feenstra L, de Jongste JC. Nasal NO: normal values in children age 6 through to 17 years. Eur Respir J 2005;26:453-457.
39. Kharitonov SA, Walker L, Barnes PJ. Repeatability of standardised nasal nitric oxide measurements in healthy and asthmatic adults and children. Respir Med 2005;99:1105-1114.
40. Santamaria F, De Stefano S, Montella S, Barbarano F, Iacotucci P, Ciccarelli R, Sofia M, Maniscalco M. Nasal nitric oxide assessment in primary ciliary dyskinesia using aspiration, exhalation, and humming. Med Sci Monit 2008;14:80-85.
41. Piacentini GL, Bodini A, Peroni D, Rigotti E, Pigozzi R, Pradal U, Boner AL. Nasal nitric oxide for early diagnosis of primary ciliary dyskinesia: practical issues in children. Respir Med 2008;102: 541-547.
42. Gupta R, Gupta N, Turner SW. A methodology for measurements of nasal nitric oxide in children under 5 yr. Pediatr Allergy Immunol 2008;19:233-238.
43. Chang CC, Liu TY, Hua YM, Lee CM, Yuh YS. Endogenous nitric oxide in the nasal airways of healthy term newborn infants in Taiwan. Pediatr Neonatol 2008;49:166-170.
44. Carraro S, Cutrone C, Cardarelli C, Zanconato S, Baraldi E. Clinical application of nasal nitric oxide measurement. Int J Immunopathol Pharmacol 2010;23:50-52.
45. Piacentini GL, Bodini A, Peroni DG, Sandri M, Brunelli M, Pigozzi R, Boner AL. Nasal nitric oxide levels in healthy preschool children. Pediatr Allergy Immunol 2010;21:1139-1145.
46. Marthin JK, Nielsen KG. Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia. Eur Respir J 2011;37:559-565.
47. Mateos-Corral D, Coombs R, Grasemann H, Ratjen F, Dell SD. Diagnostic value of nasal nitric oxide measured with non-velum closure techniques for children with primary ciliary dyskinesia. J Pediatr 2011;159:420-424.
48. Montella S, Alving K, Maniscalco M, Sofia M, De Stefano S, Raia V, Santamaria F. Measurement of nasal nitric oxide by hand-held and stationary devices. Eur J Clin Invest 2011;41:1063-1070.
49. Zhou M, Liu Y, Duan Y. Breath biomarkers in diagnosis of pulmonary diseases. Clin Chim Acta 2012;413:1770-1780.
50. Marthin JK, Nielsen KG. Hand-held tidal breathing nasal nitric oxide measurement - a promising targeted case-finding tool for the diagnosis of primary ciliary dyskinesia. PLoS One 2013;8: e57262.
51. Walker WT, Liew A, Harris A, Cole J, Lucas JS. Upper and lower airway nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and asthma. Respir Med 2013;107:380-386.
52. Leigh MW, Hazucha MJ, Chawla KK, Baker BR, Shapiro AJ, Brown DE, Lavange LM, Horton BJ, Qaqish B, Carson JL, et al. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc 2013;10:574-581.
53. Sahin G, Klimek L, Mullol J, Hörmann K, Walther LE, Pfaar O. Nitric oxide: a promising methodological approach in airway diseases. Int Arch Allergy Immunol 2011;156:352-361.
54. Torretta S, Bossi A, Capaccio P, Marchisio P, Esposito S, Brevi A, Pignataro L. Nasal nitric oxide in children with adenoidal hypertrophy: a preliminary study. Int J Pediatr Otorhinolaryngol 2010;74:689-693.
55. Keen C, Olin AC, Edentoft A, Gronowitz E, Strandvik B. Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids. Chest 2007;131:1857-1864.
56. Weitzberg E, Lundberg JO. Humming greatly increases nasal nitric oxide. Am J Respir Crit Care Med 2002;166:144-145.
57. Lundberg JO, Maniscalco M, Sofia M, Lundblad L, Weitzberg E. Humming, nitric oxide, and paranasal sinus obstruction. JAMA 2003;289:302-303.
58. Struben VM, Sewbalak WV, Wieringa MH, Mantingh CJ, van den Toorn LM, Bakker M, Feenstra L, de Jongste JC. Nasal nitric oxide in cystic fibrosis with and without humming. Eur J Clin Invest 2007;37:140-144.
59. Maniscalco M, Lundberg JO. Nasal nitric oxide. In: Horvath I, de Jongste JC, editors Exhaled Biomarkers. European Respiratory Society Monograph. 2010. 49:71-81.
60. Imada M, Iwamoto J, Nonaka S, Kobayashi Y, Unno T. Measurement of nitric oxide in human nasal airway. Eur Respir J 1996;9:556-559.
61. Aikio O, Pokela ML, Hallman M. Exhaled and nasal nitric oxide in mechanically ventilated preterm and term newborns. Acta Paediatr 2002;91:1078-1086.
62. Maniscalco M, de Laurentiis G, Weitzberg E, Lundberg JO, Sofia M. Validation study of nasal nitric oxide measurements using a hand-held electrochemical analyser. Eur J Clin Invest 2008;38:197-200.
63. Abete P, Adlbrecht C, Assimakopoulos SF, Côte N, Dullaart RPF, Evsyukova HV, Fang T-C, Goswami N, Hinghofer-Szalkay H, Ho Y-L, et al. Research update for articles published in EJCI in 2011. Eur J Clin Invest 2013;43:1097-1110.
64. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1368-1370.
65. Lundberg JO, Rinder J, Weitzberg E, Lundberg JM, Alving K. Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses. Acta Physiol Scand 1994;152:431-432.
66. Lewandowski K, Busch T, Lohbrunner H, Rensing S, Keske U, Gerlach H, Falke KJ. Low nitric oxide concentrations in exhaled gas and nasal airways of mammals without paranasal sinuses. J Appl Physiol (1985) 1998;85:405-410.
67. Lundberg JO. Nitric oxide and the paranasal sinuses. Anat Rec (Hoboken) 2008;291:1479-1484.
68. Irander K, Borres MP, Palm JP. Acoustic rhinometry, spirometry and nitric oxide in relation to airway allergy and smoking habits in an adolescent cohort. Int J Pediatr Otorhinolaryngol 2011;75:177-181.
69. Bartley J, Fergusson W, Moody A, Wells AU, Kolbe J. Normal adult values, diurnal variation, and repeatability of nasal nitric oxide measurement. Am J Rhinol 1999;13:401-405.
70. Stark H, Purokivi M, Kiviranta J, Randell J, Tukiainen H. Short-term and seasonal variations of exhaled and nasal NO in healthy subjects. Respir Med 2007;101:265-271.
71. Lundberg JO, Rinder J, Weitzberg F, Alving K, Lundberg JM. Heavy physical exercise decreases nitric oxide levels in the nasal airways in humans. Acta Physiol Scand 1997;159:51-57.
72. Westerveld GJ, Voss HP, van der Hee RM, de Haan-Koelewijn GJ, den Hartog GJ, Scheeren RA, Bast A. Inhibition of nitric oxide synthase by nasal decongestants. Eur Respir J 2000;16:437 444.
73. Yamada T, Yamamoto H, Kubo S, Sakashita M, Tokunaga T, Susuki D, Narita N, Ogi K, Kanno M, Yamashita S, et al. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis. Allergy Asthma Proc 2012;33: e9-16.
74. Alobid I, Benitez P, Valero A, Munoz R, Langdon C, Mullol J. Oral and intranasal steroid treatments improve nasal patency and paradoxically increase nasal nitric oxide in patients with severe nasal polyposis. Rhinology 2012;50:171-177.
75. Gehring U, Oldenwening M, Brunekreef B, Wieringa MH, Kerkhof M, Smit HA, van der Ent CK, De Jongste JC. The impact of ambient NO on online measurements ofexhaledandnasal NO: the PIAMA study. Pediatr Allergy Immunol 2009;20:665-672.
76. Jorissen M, Lefevere L, Willems T. Nasal nitric oxide. Allergy 2001;56:1026-1033.
77. Struben VM, Wieringa MH, Mantingh CJ, de Jongste JC, Feenstra L. Nasal NO measurement by direct sampling from the nose during breathold: aspiration flow, nasal resistance and reproducibility. Eur Arch Otorhinolaryngol 2006;263: 723-728.
78. Kemp AS. Allergic rhinitis. Paediatr Respir Rev 2009;10: 63-68.
79. Kawamoto H, Takeno S, Yajin K. Increased expression of inducible nitric oxide synthase in nasal epithelial cells in patients with allergic rhinitis. Laryngoscope 1999;109:2015-2020.
80. Linhares D, Jacinto T, Pereira AM, Fonseca JA. Effects of atopy and rhinitis on exhaled nitric oxide values - a systematic review. Clin Transl Allergy 2011;1:8.
81. Barnes ML, Ward JH, Fardon TC, Lipworth BJ. Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. Clin Exp Allergy 2006;36:676-684.
82. Profita M, La Grutta S, Carpagnano E, Riccobono L, Di Giorgi R, Bonanno A, Pace E, Bonsignore G, Bousquet J, Vignola AM, et al. Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 2006;118:1068-1074.
83. Marcucci F, Sensi LG, Abate P, Allocca G, Ugolini E, Di Cara G, Incorvaia C. Anti-inflammatory activity and clinical efficacy of a 3-month levocetirizine therapy in mite-allergic children. Inflamm Allergy Drug Targets 2011;10:32-38.
84. Lee KJ, Cho SH, Lee SH, Tae K, Yoon HJ, Kim SH, Jeong JH. Nasal and exhaled nitric oxide in allergic rhinitis. Clin Exp Otorhinolaryngol 2012;5:228-233.
85. Profita M, Riccobono L, Bonanno A, Chanez P, Gagliardo R, Montalbano AM, Albano GD, Liotta G, Gjomarkaj M, La Grutta S. Effect of nebulized beclomethasone on airway inflammation and clinical status of children with allergic asthma and rhinitis: a randomized, double-blind, placebo-controlled study. Int Arch Allergy Immunol 2013;161:53-64.
86. Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy 2007;62:73-80.
87. Pedroletti C, Lundahl J, Alving K, Hedlin G. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma. Pediatr Allergy Immunol 2008;19:219-226.
88. Struben VM, Wieringa MH, Feenstra L, de Jongste JC. Nasal nitric oxide and nasal allergy. Allergy 2006;61:665-670.
89. Howarth PH, Persson CG, Meltzer EO, Jacobson MR, Durham SR, Silkoff PE. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol 2005;115:S414-441.
90. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-457.
91. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C. et al. World Health Organization. GA(2)LEN. AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63:8-160.
92. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 2012;3:1-298.
93. Leo G, Piacentini E, Incorvaia C, Consonni D, Frati F. Chronic rhinosinusitis and allergy. Pediatr Allergy Immunol 2007;18:19-21.
94. Bommarito L, Guida G, Heffler E, Badiu I, Nebiolo F, Usai A, De Stefani A, Rolla G. Nasal nitric oxide concentration in suspected chronic rhinosinusitis. Ann Allergy Asthma Immunol 2008;101: 358-362.
95. Naraghi M, Deroee AF, Ebrahimkhani M, Kiani S, Dehpour A. Nitric oxide: a new concept in chronic sinusitis pathogenesis. Am J Otolaryngol 2007;28:334-337.
96. Phillips PS, Sacks R, Marcells GN, Cohen NA, Harvey RJ. Nasal nitric oxide and sinonasal disease: a systematic review of published evidence. Otolaryngol Head Neck Surg 2011;144:159-169.
97. Scadding G. Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. Pediatr Allergy Immunol 2010;21:1095-1106.
98. Unal M, Cimen MY, Doʇruer ZN, Cevik T. The potential inflammatory role of arginase and iNOS in children with chronic adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 2005;69: 381-385.
99. Tennyson AG, Lippard SJ. Generation, translocation, and action of nitric oxide in living systems. Chem Biol 2011;18:1211-1220.
100. McCarthy VA, Harris A. The CFTR gene and regulation of its expression. Pediatr Pulmonol 2005;40:1-8.
101. de Winter-de Groot KM, van Haren Noman S, Speleman L, Schilder AG, van der Ent CK. Nasal nitric oxide levels and nasal polyposis in children and adolescents with cystic fibrosis. JAMA Otolaryngol Head Neck Surg 2013;139:931-936.
102. Grasemann H, Ratjen F. Cystic fibrosis lung disease: the role of nitric oxide. Pediatr Pulmonol 1999;28:442-448.
103. Grasemann H, Storm van's, Gravesande K, Gärtig S, Kirsch M, Büscher R, Drazen JM, Ratjen F. Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism. Nitric Oxide 2002;6:236-241.
104. Grasemann H, Ratjen F. Nitric oxide and L-arginine deficiency in cystic fibrosis. Curr Pharm Des 2012;18:726-736.
105. Michl RK, Hentschel J, Fischer C, Beck JF, Mainz JG. Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers. PLoS One 2013; 13; 8: e79141.
106. Hildebrandt F, Benzing T, Katsanis N. Ciliopathies. N Engl J Med 2011;364:1533-1543.
107. Bush A, Chodhari R, Collins N, Copeland F, Hall P, Harcourt J, Hariri M, Hogg C, Lucas J, Mitchison HM, et al. Primary ciliary dyskinesia: current state of the art. Arch Dis Child 2007;92: 1136-1140.
108. Santamaria F, de Santi MM, Grillo G, Sarnelli P, Caterino M, Greco L. Ciliary motility at light microscopy: a screening technique for ciliary defects. Acta Paediatr 1999;88:853-857.
109. Pifferi M, Caramella D, Cangiotti AM, Ragazzo V, Macchia P, Boner AL. Nasal nitric oxide in atypical primary ciliary dyskinesia. Chest 2007;131:870-873.
110. Narang I, Ersu R, Wilson NM, Bush A. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002;57:586-589.
111. Knowles MR, Daniels LA, Davis SD, Zariwala MA, Leigh MW. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Respir Crit Care Med 2013;188:913-922.
112. Pifferi M, Bush A, Caramella D, Di Cicco M, Zangani M, Chinellato I, Macchia P, Boner AL. Agenesis of paranasal sinuses and nasal nitricoxide in primary ciliary dyskinesia. Eur Respir J 2011;37:566-571.
113. Wodehouse T, Kharitonov SA, Mackay IS, et al. Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur Respir J 2003;21:43-47.
114. Mahut B, Escudier E, de Blic J, Zerah-Lancner F, Coste A, Harf A, Delclaux C. Impairment of nitric oxide output of conducting airways in primary ciliary dyskinesia. Pediatr Pulmonol 2006;41: 158-163.
115. Walker WT, Jackson CL, Lackie PM, Hogg C, Lucas JS. Nitric oxide in primary ciliary dyskinesia. Eur Respir J 2012;40:1024-1032.
116. Maniscalco M, Sofia M. Nasal nitric oxide in experimental rhinovirus infection. J Allergy Clin Immunol 2005;115:207.
117. Smith CM, Fadaee-Shohada MJ, Sawhney R, Baker N, Williams G, Hirst RA, Andrew PW, O'Callaghan C. Ciliated cultures from patients with primary ciliary dyskinesia do not produce nitric oxide or inducible nitric oxide synthase during early infection. Chest 2013;144:1671-1676.
118. Grasemann H, Schwiertz R, Matthiesen S, Racke K, Ratjen F. Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med 2005;172:1523-1528.
119. Baraldi E, Pasquale MF, Cangiotti AM, Zanconato S, Zacchello F Nasal nitric oxide is low early in life: case study of two infants with primary ciliary dyskinesia. Eur Respir J 2004;24:881-883.
120. Ellerman A, Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Eur Respir J 1997;10: 2376-2379.
121. Marthin JK, Petersen N, Skovgaard LT, Nielsen KG. Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study. Am J Respir Crit Care Med 2010;181:1262-1268.